Patents by Inventor Simon Cool

Simon Cool has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11957132
    Abstract: A method of storing potatoes, the method comprising the steps of: i. providing a plurality of dormant potatoes, wherein the potatoes have been cured after harvesting; ii. treating the potatoes with 1-methylcyclopropene, the treatment comprising exposing the potatoes, which are at a first treatment temperature within the range of from 10 to 30° C., to 1-methylcyclopropene; storing the potatoes at a second storage temperature within the range of from greater than 1 to up to 6° C. for a storage period within a potato store, wherein the storage period extends continuously until at least 1 week after initiation of eye movement in at least one of the potatoes, and wherein during the storage period the potatoes are stored in atmospheric air free of an external supply of ethylene sprout suppressant.
    Type: Grant
    Filed: November 10, 2020
    Date of Patent: April 16, 2024
    Assignee: Frito-Lay Trading Company GmbH
    Inventors: Gemma A. Chope, Simon C. McWilliam, Leon A. Terry, Katherine Cools, Roberta Tosetti
  • Patent number: 11806368
    Abstract: A method for providing a sub-population of stem cell or plurality of stem cells by determining or modulating GSTT1 expression level or genotype is disclosed together with uses of the stem cells.
    Type: Grant
    Filed: May 15, 2020
    Date of Patent: November 7, 2023
    Assignee: Agency for Science, Technology and Research
    Inventors: Lawrence Stanton, Padmapriya Sathiyanathan, Simon Cool, Victor Nurcombe, Rebekah M. Samsonraj
  • Publication number: 20200345782
    Abstract: A method for providing a sub-population of stem cell or plurality of stem cells by determining or modulating GSTT1 expression level or genotype is disclosed together with uses of the stem cells.
    Type: Application
    Filed: May 15, 2020
    Publication date: November 5, 2020
    Inventors: Lawrence Stanton, Padmapriya Sathiyanathan, Simon Cool, Victor Nurcombe, Rebekah M. Samsonraj
  • Patent number: 10723813
    Abstract: Affinity purification of platelet-derived growth factor-binding heparan sulphate from porcine mucosa (HS6) is disclosed. Also disclosed is the use of HS6 in repair and regeneration of the skin for treating wounds, burns, ulcers and other skin injuries.
    Type: Grant
    Filed: January 8, 2016
    Date of Patent: July 28, 2020
    Assignee: Agency for Science, Technology and Research
    Inventors: Simon Cool, Victor Nurcombe
  • Patent number: 10596296
    Abstract: A heparan sulphate that binds TGP?1 is disclosed.
    Type: Grant
    Filed: April 30, 2015
    Date of Patent: March 24, 2020
    Assignee: Agency for Science, Technology and Research
    Inventors: Simon Cool, Victor Nurcombe, Jonathan Lee
  • Patent number: 10493012
    Abstract: Affinity purification of fibroblast growth factor 2-binding heparan sulphate from porcine mucosa (HS8) is disclosed. Also disclosed is a process for the care of keratinous material(s), comprising the application or administration of HS8, or a composition comprising thereof, to keratinous material(s). The composition may be used to improve the condition of skin, such as smoothing the skin, restoring skin elasticity and firmness, or decreasing or preventing wrinkles, and may be formulated for topical or transdermal administration.
    Type: Grant
    Filed: November 19, 2015
    Date of Patent: December 3, 2019
    Assignees: Agency for Science, Technology and Research, L'Oreal
    Inventors: Simon Cool, Victor Nurcombe, Charbel Bouez, Diah Saraswati Bramono
  • Patent number: 10471091
    Abstract: Affinity purification of fibroblast growth factor 2-binding heparan sulphate from porcine mucosa (HS8) is disclosed. Also disclosed is the use of HS8 in repair and regeneration of the skin for treating wounds, burns, ulcers and other skin injuries.
    Type: Grant
    Filed: November 19, 2015
    Date of Patent: November 12, 2019
    Assignee: Agency for Science, Technology and Research
    Inventors: Simon Cool, Victor Nurcombe
  • Publication number: 20190135949
    Abstract: A heparan sulphate that binds vitronectin is disclosed.
    Type: Application
    Filed: January 15, 2019
    Publication date: May 9, 2019
    Inventors: Simon Cool, Victor Nurcombe
  • Patent number: 10266612
    Abstract: A novel class of structurally and functionally related isolated Heparan sulphate is disclosed. The novel class of Heparan sulphates has been found to bind FGF2 and enhance the proliferation of stem cells while maintaining their pluripotency/multipotency.
    Type: Grant
    Filed: May 16, 2013
    Date of Patent: April 23, 2019
    Assignee: Agency for Science, Technology and Research
    Inventors: Victor Nurcombe, Simon Cool
  • Patent number: 10245281
    Abstract: Heparan sulphate HS7 is disclosed, together with the use of HS7 in the growth and/or development and/or regeneration of tissue.
    Type: Grant
    Filed: July 31, 2015
    Date of Patent: April 2, 2019
    Assignee: Agency for Science, Technology and Research
    Inventors: Simon Cool, Victor Nurcombe
  • Publication number: 20180258193
    Abstract: Affinity purification of platelet-derived growth factor-binding heparan sulphate from porcine mucosa (HS6) is disclosed. Also disclosed is the use of HS6 in repair and regeneration of the skin for treating wounds, burns, ulcers and other skin injuries.
    Type: Application
    Filed: January 8, 2016
    Publication date: September 13, 2018
    Inventors: Simon Cool, Victor Nurcombe
  • Publication number: 20170326059
    Abstract: Affinity purification of fibroblast growth factor 2-binding heparan sulphate from porcine mucosa (HS8) is disclosed. Also disclosed is a process for the care of keratinous material(s), comprising the application or administration of HS8, or a composition comprising thereof, to keratinous material(s). The composition may be used to improve the condition of skin, such as smoothing the skin, restoring skin elasticity and firmness, or decreasing or preventing wrinkles, and may be formulated for topical or transdermal administration.
    Type: Application
    Filed: November 19, 2015
    Publication date: November 16, 2017
    Inventors: Simon Cool, Victor Nurcombe, Charbel Bouez, Diah Saraswati Bramono
  • Publication number: 20170319615
    Abstract: Affinity purification of fibroblast growth factor 2-binding heparan sulphate from porcine mucosa (HS8) is disclosed. Also disclosed is the use of HS8 in repair and regeneration of the skin for treating wounds, burns, ulcers and other skin injuries.
    Type: Application
    Filed: November 19, 2015
    Publication date: November 9, 2017
    Inventors: Simon Cool, Victor Nurcombe
  • Publication number: 20170143766
    Abstract: A method for providing a sub-population of stem cell or plurality of stem cells by determining or modulating GSTT1 expression level or genotype is disclosed together with uses of the stem cells.
    Type: Application
    Filed: June 26, 2015
    Publication date: May 25, 2017
    Inventors: Lawrence Stanton, Padmapriya Sathiyanathan, Simon Cool, Victor Nurcombe, Rebekah M. Samsonraj
  • Publication number: 20170043053
    Abstract: A heparan sulphate that binds TGP?1 is disclosed.
    Type: Application
    Filed: April 30, 2015
    Publication date: February 16, 2017
    Inventors: Simon Cool, Victor Nurcombe, Jonathan Lee
  • Publication number: 20160215072
    Abstract: A heparan sulphate that binds vitronectin is disclosed.
    Type: Application
    Filed: May 27, 2014
    Publication date: July 28, 2016
    Inventors: Simon Cool, Victor Nurcombe
  • Patent number: 9359452
    Abstract: Heparan sulphates isolated from male and female murine liver, their characterisation and use in pharmaceutical compositions, methods of treatment and in stem cell culture media suitable for conditions associated with bone repair.
    Type: Grant
    Filed: November 19, 2010
    Date of Patent: June 7, 2016
    Assignee: Agency for Science, Technology and Research
    Inventors: Simon Cool, Victor Nurcombe, Murali Sadasivam
  • Patent number: 9333257
    Abstract: The use of an FGFR1 antibody in the treatment of cancer is disclosed, wherein the FGFR1 antibody binds FGFR1 at an epitope that is positioned in the FGFR1 primary amino acid sequence no more than 50 contiguous amino acids away from the C- or N-terminal of the FGFR1 heparin binding domain.
    Type: Grant
    Filed: March 14, 2012
    Date of Patent: May 10, 2016
    Assignee: Agency for Science, Technology and Research
    Inventors: Simon Cool, Victor Nurcombe, Ling Ling
  • Publication number: 20160115251
    Abstract: A novel class of structurally and functionally related isolated Heparan sulphate is disclosed. The novel class of Heparan sulphates has been found to bind FGF2 and enhance the proliferation of stem cells whilst maintaining their pluripotency/multipotency.
    Type: Application
    Filed: May 16, 2013
    Publication date: April 28, 2016
    Inventors: Victor Nurcombe, Simon Cool
  • Publication number: 20150328251
    Abstract: Heparan sulphate HS7 is disclosed, together with the use of HS7 in the growth and/or development and/or regeneration of tissue.
    Type: Application
    Filed: July 31, 2015
    Publication date: November 19, 2015
    Inventors: Simon Cool, Victor Nurcombe